BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 20383176)

  • 1. Receptor-interacting protein (RIP) kinase family.
    Zhang D; Lin J; Han J
    Cell Mol Immunol; 2010 Jul; 7(4):243-9. PubMed ID: 20383176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspase recruitment domain protein 6 is a microtubule-interacting protein that positively modulates NF-kappaB activation.
    Dufner A; Pownall S; Mak TW
    Proc Natl Acad Sci U S A; 2006 Jan; 103(4):988-93. PubMed ID: 16418290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The essential role of the death domain kinase receptor-interacting protein in insulin growth factor-I-induced c-Jun N-terminal kinase activation.
    Lin Y; Yang Q; Wang X; Liu ZG
    J Biol Chem; 2006 Aug; 281(33):23525-32. PubMed ID: 16793775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of CARDIAK, a RIP-like kinase that associates with caspase-1.
    Thome M; Hofmann K; Burns K; Martinon F; Bodmer JL; Mattmann C; Tschopp J
    Curr Biol; 1998 Jul; 8(15):885-8. PubMed ID: 9705938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of NF-kappaB activation by tumor necrosis factor alpha receptor complex-targeted MEKK3 in receptor-interacting protein-deficient cells.
    Blonska M; You Y; Geleziunas R; Lin X
    Mol Cell Biol; 2004 Dec; 24(24):10757-65. PubMed ID: 15572679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of RIP-2 kinase by proinflammatory cytokines is mediated via NF-kappaB signaling pathways and involves a novel feed-forward regulatory mechanism.
    Yin X; Krikorian P; Logan T; Csizmadia V
    Mol Cell Biochem; 2010 Jan; 333(1-2):251-9. PubMed ID: 19693652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RIP kinases at the crossroads of cell death and survival.
    Declercq W; Vanden Berghe T; Vandenabeele P
    Cell; 2009 Jul; 138(2):229-32. PubMed ID: 19632174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CARD tricks: controlling the interactions of CARD6 with RICK and microtubules.
    Dufner A; Mak TW
    Cell Cycle; 2006 Apr; 5(8):797-800. PubMed ID: 16582588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAK1 is recruited to the tumor necrosis factor-alpha (TNF-alpha) receptor 1 complex in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading to NF-kappaB activation.
    Blonska M; Shambharkar PB; Kobayashi M; Zhang D; Sakurai H; Su B; Lin X
    J Biol Chem; 2005 Dec; 280(52):43056-63. PubMed ID: 16260783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic Biology Reveals the Uniqueness of the RIP Kinase Domain.
    Chirieleison SM; Kertesy SB; Abbott DW
    J Immunol; 2016 May; 196(10):4291-7. PubMed ID: 27045108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex.
    Hsu H; Huang J; Shu HB; Baichwal V; Goeddel DV
    Immunity; 1996 Apr; 4(4):387-96. PubMed ID: 8612133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the death-domain kinase RIP in tumour-necrosis-factor-induced activation of mitogen-activated protein kinases.
    Devin A; Lin Y; Liu ZG
    EMBO Rep; 2003 Jun; 4(6):623-7. PubMed ID: 12776182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitor ABIN-2 disrupts the interaction of receptor-interacting protein with the kinase subunit IKKgamma to block activation of the transcription factor NF-kappaB and potentiate apoptosis.
    Liu WK; Yen PF; Chien CY; Fann MJ; Su JY; Chou CK
    Biochem J; 2004 Mar; 378(Pt 3):867-76. PubMed ID: 14653779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plant and animal pathogen recognition receptors signal through non-RD kinases.
    Dardick C; Ronald P
    PLoS Pathog; 2006 Jan; 2(1):e2. PubMed ID: 16424920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RIP kinases initiate programmed necrosis.
    Galluzzi L; Kepp O; Kroemer G
    J Mol Cell Biol; 2009 Oct; 1(1):8-10. PubMed ID: 19679643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting RIP Kinases in Chronic Inflammatory Disease.
    Speir M; Djajawi TM; Conos SA; Tye H; Lawlor KE
    Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33924766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RIP kinases: key decision makers in cell death and innate immunity.
    Humphries F; Yang S; Wang B; Moynagh PN
    Cell Death Differ; 2015 Feb; 22(2):225-36. PubMed ID: 25146926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Structural Basis of Necroptotic Cell Death Signaling.
    Petrie EJ; Czabotar PE; Murphy JM
    Trends Biochem Sci; 2019 Jan; 44(1):53-63. PubMed ID: 30509860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal adhesion kinase determines the fate of death or survival of cells in response to TNFalpha in the presence of actinomycin D.
    Takahashi R; Sonoda Y; Ichikawa D; Yoshida N; Eriko AY; Tadashi K
    Biochim Biophys Acta; 2007 Apr; 1770(4):518-26. PubMed ID: 17197095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase.
    Lin Y; Devin A; Cook A; Keane MM; Kelliher M; Lipkowitz S; Liu ZG
    Mol Cell Biol; 2000 Sep; 20(18):6638-45. PubMed ID: 10958661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.